Members on the Move

Kevin MacDonald, Ph.D., was promoted to the position of Shareholder at Wolf, Greenfield & Sacks. Kevin assists clients with IP strategy and portfolio management, and patent prosecution and counseling, across a wide range of technologies including cell and gene therapy, RNA interference, bioinformatics, mRNA therapeutics, and biologics manufacturing. Kevin represents clients across the spectrum including venture-backed start-ups, large biopharma, public and private universities, and research institutions. He also represents clients in buy- and sell-side IP due diligence, and drafting and negotiating IP-centric agreements, such as licensing agreements, sponsored research agreements, and technology collaboration agreements. Kevin is named to the list of Massachusetts Rising Stars by Super Lawyers and is recognized on the Best Lawyers: One to Watch list by The Best Lawyers in America®.

Erin Foley has joined Foley Hoag LLP as Counsel in the Intellectual Property Department and as a member of the Patent Prosecution, Strategy & Management and PTAB Proceedings practices. She is resident in the firm’s Boston office.  Erin's practice focuses on devising and implementing global patent and exclusivity strategies, leading IP diligence for both target-side and buyer-side companies and providing patent support in partnership and licensing negotiations. Erin devises and executes global intellectual property strategies for early-stage, mid-sized and commercial companies across life sciences sectors, including gene editing, gene therapy, viral vector engineering, RNA-based therapies, monoclonal antibodies, CAR-T therapies, stem cell therapies, vaccines, antimicrobial therapies, DNA sequencing, and food science.